Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in

Related Experiment Video

Updated: Aug 20, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

Tiemin Wei1, Chunlai Zeng, Liping Chen

  • 1Department of Cardiology, Lishui City Central Hospital, Zhejiang Province, PR China. lswtm@sina.com

European Journal of Heart Failure
|January 12, 2005
PubMed

Insights

Plasma B-type natriuretic peptide (BNP) levels effectively aid in diagnosing diastolic dysfunction in hypertension patients. Elevated BNP correlates with impaired heart function, offering a sensitive and specific diagnostic marker.

Area of Science:

  • Cardiology
  • Biomarkers
  • Hypertension Research

Background:

  • Left ventricular diastolic dysfunction (LVDD) is a common complication in hypertensive patients.
  • Early diagnosis of LVDD is crucial for timely intervention and improved patient outcomes.
  • B-type natriuretic peptide (BNP) is a hormone released in response to cardiac strain.

Purpose of the Study:

  • To evaluate the diagnostic utility of plasma B-type natriuretic peptide (BNP) for left ventricular diastolic dysfunction (LVDD) in hypertensive individuals.
  • To determine the correlation between BNP levels and echocardiographic parameters of diastolic function.

Main Methods:

  • Prospective assessment of left ventricular diastolic function and plasma BNP levels in 135 hypertensive patients.
  • Echocardiography was used to diagnose LVDD.
  • Statistical analysis, including receiver-operator characteristic (ROC) curve analysis, was performed.

Main Results:

  • Plasma BNP levels were significantly higher in patients with LVDD (122+/-105 pg/ml) compared to those without (18+/-16 pg/ml) (p<0.001).
  • BNP levels correlated with systolic blood pressure, left ventricular mass index, E/A ratio, and isovolumic relaxation time.
  • The ROC curve demonstrated high accuracy (area under the curve = 0.904) for BNP in diagnosing LVDD.
  • A cut-off value of >40 pg/ml yielded 79% sensitivity and 92% specificity for LVDD.

Conclusions:

  • Plasma BNP levels are closely associated with left ventricular hypertrophy and impaired diastolic filling in hypertensive patients.
  • Plasma BNP serves as a valuable, non-invasive biomarker to facilitate the diagnosis of LVDD in hypertension.
  • BNP testing can aid clinicians in identifying hypertensive patients requiring further evaluation for diastolic dysfunction.
Abstract

More Related Videos

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease08:57

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease

Published on: May 22, 2026

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension07:38

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension

Published on: January 20, 2023

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...